3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
Compound with spectra: 1 NMR
![3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL](/api/compound/4Dq0KDIrF0R.png?ph=true&h=300&w=458 "3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL")
| SpectraBase Compound ID | 4Dq0KDIrF0R |
|---|---|
| InChI | InChI=1S/C31H41N3O3/c1-19-6-5-7-21(14-19)28-18-34(33-32-28)17-22-15-27-25-9-8-23-16-24(37-20(2)35)10-12-30(23,3)26(25)11-13-31(27,4)29(22)36/h5-8,14,18,22,24-27,29,36H,9-13,15-17H2,1-4H3/t22-,24+,25-,26+,27+,29+,30+,31+/m1/s1 |
| InChIKey | IWJQREQRXIFHRV-XQQVQZKWSA-N |
| Mol Weight | 503.7 g/mol |
| Molecular Formula | C31H41N3O3 |
| Exact Mass | 503.314792 g/mol |
| Enantiomer InChIKey | IWJQREQRXIFHRV-ACIPEIFOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-BETA-ACETOXY-16-BETA-[4-(3-AMINOPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-PHENYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(4-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(4-ETHYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(4-TERT.-BUTYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(5-ACETYL-1H-TETRAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-ALPHA-DIOL-DIACETATE
3,17a-Diacetoxy-16a-methyleneacetoxy.delta. 5(6)-androsten
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and In Vitro Antiproliferative Activity of Novel Androst-5-ene Triazolyl and Tetrazolyl Derivatives | Molecules | 2011 |